Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Rxsight Inc RXST

Healthcare Medical Devices
RxSight, Inc. is a commercial-stage medical technology company, which is engaged in improving the vision of patients following cataract surgery. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL... see more

Recent & Breaking News (NDAQ:RXST)

RxSight, Inc. to Report Third Quarter 2022 Financial Results on November 7, 2022

GlobeNewswire October 24, 2022

RxSight, Inc. to Present at the Wells Fargo Healthcare Conference

GlobeNewswire August 24, 2022

RxSight, Inc. Files Shelf Registration Statement and Announces $50 Million At-The-Market Equity Offering Program

GlobeNewswire August 8, 2022

RxSight, Inc. Reports Second Quarter 2022 Financial Results

GlobeNewswire August 8, 2022

RxSight, Inc. to Report Second Quarter 2022 Financial Results on August 8, 2022

GlobeNewswire July 25, 2022

RxSight, Inc. Reports First Quarter 2022 Financial Results

GlobeNewswire May 5, 2022

RxSight, Inc. to Present at the Bank of America Healthcare Conference

GlobeNewswire April 22, 2022

RxSight, Inc. to Report First Quarter 2022 Financial Results on May 5, 2022 

GlobeNewswire April 21, 2022

Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting

GlobeNewswire April 19, 2022

RxSight, Inc. to Present at the Needham Virtual Healthcare Conference

GlobeNewswire March 28, 2022

RxSight, Inc. Reports Fourth Quarter and Fiscal Year 2021 Financial Results

GlobeNewswire March 8, 2022

Inari Medical Appoints Robert Warner to Board of Directors

GlobeNewswire March 1, 2022

RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 8, 2022

GlobeNewswire February 23, 2022

RxSight, Inc. to Present at the SVB Leerink Global Healthcare Conference

GlobeNewswire February 3, 2022

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Financial and Operational Results

GlobeNewswire January 9, 2022

RxSight, Inc. Appoints Dr. Tamara R. Fountain, M.D. and Shweta Singh Maniar to its Board of Directors

GlobeNewswire January 4, 2022

RxSight to Present at the J.P. Morgan Healthcare Conference

GlobeNewswire December 28, 2021

RxSight to Participate in the Ophthalmology Day at BTIG

GlobeNewswire November 18, 2021

RxSight Reports Third Quarter 2021 Financial Results

GlobeNewswire November 10, 2021

RxSight to Report Third Quarter 2021 Financial Results on November 10, 2021

GlobeNewswire October 27, 2021